PANASONIC
26.5.2020 12:50:05 CEST | Business Wire | Press release
Panasonic Center Tokyo (3-5-1 Ariake, Koto-ku, Tokyo, Japan. Referred to as "PC Tokyo"), the corporate global communications hub for Panasonic, has been conducting various communication activities as a corporate pavilion through exhibitions and offline events.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005385/en/
Due to the unprecedented circumstances around the world today, people's daily lives and values have been significantly impacted. We, at Panasonic, believe a new approach blending online and offline communication activities will be an essential element for corporate pavilions now more than ever.
Based on this perspective, we have decided to host an online event called "The power to create the future", on Sunday, May 31, 2020. An event dedicated to children, who we believe have the ability to become "change makers" and bring a positive impact to society, to create a better world.
The theme of the event is "STEAM education*", a very important element required for future education as the world is rapidly changing. During the event, STEAM professionals will conduct a workshop which will give the participants an opportunity to think and understand more about STEAM in their daily lives. Olympian Katie Ledecky will also join the event to introduce the Dive Into STEM Education, Powered by Panasonic program.
Katie Ledecky's Dive Into STEM Education Powered by Panasonic is an interactive educational program created to inspire students to pursue careers in science, technology, engineering and mathematics.
The students participating in the event will be divided into different groups where they will conduct a series of interviews with our guests to learn more about STEAM, and then will make a presentation about what they have learned. At the end of the event, participants will hear from Katie, who is actively working on educational support activities for younger generations.
PC Tokyo aims to proactively support the education program of younger generations by providing fresh contents such as videos of online events available on the pavilion's website.
Message from Katie Ledecky towards the event
"I am thrilled to join Panasonic Center Tokyo to promote STEM education to a group of Japanese students on May 31st.
All are welcome to join our training workshop. Hope to see you soon."
Video: “Katie Ledecky's Dive Into STEM Education Powered by Panasonic”
https://youtu.be/31DmQXq0sTw
*STEAM education is an educational method which was proposed by adding Art to "STEM education"; a method to learn about Science, Technology, Engineering, and Mathematics comprehensively.
STEAM education was introduced in the United States to contribute to the development of younger generations to inspire them to pursue diverse career fields. This method is also attracting a lot of attention in Japan in recent years.
"The power to create the future" Event outline
Date
Saturday, May 30, 2020 at 6:00pm-7:40pm PDT / 9:00pm-10:40pm EDT
Sunday, May 31, 2020 at 10:00am-11:40am JST
Place
Live stream of the online event: https://youtu.be/aiLyPX7SmTM
Details: https://www.panasonic.com/global/corporate/center-tokyo/en.html#steam_0531
*The live stream is recorded and can be viewed afterwards.
Target
Junior and senior high school students, educators, and those who have interest in STEAM education
Cooperation
Kyodo News (junior press), EverFi (contents for the event)
*The event will be conducted in English. Admission free.
About Panasonic
Panasonic Corporation is a global leader developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, and B2B sectors. The company, which celebrated its 100th anniversary in 2018, operates 528 subsidiaries and 72 associated companies worldwide and reported consolidated net sales of 7.49 trillion yen for the year ended March 31, 2020. Committed to pursuing new value through collaborative innovation, the company uses its technologies to create a better life and a better world for customers. Learn more about Panasonic: https://www.panasonic.com/global .
Source: https://news.panasonic.com/global/topics/2020/78373.html
Related Links
Panasonic Center Tokyo official website
https://panasonic.com/global/center-tokyo/en/
Event Reports - Panasonic Center TOKYO
https://www.panasonic.com/global/corporate/center-tokyo/en/event_report.html#StayHome_contents
Video: Panasonic Partners With The Michael Phelps Foundation #whatmovesus
https://channel.panasonic.com/contents/28784/
Video: Team Panasonic is forward moving #whatmovesus
https://channel.panasonic.com/contents/28785/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005385/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom